Loading...

IRWD IRONWOOD PHARMACEUTICALS INC Management Changes 8-K Filing

RNWD

RWD

IRONWOOD PHARMACEUTICALS INC

(IRWD)

2024 8-K

Show Summary

Show Summary

Notice of Delisting

Financial Statements

Financial Statements

Strategic Alternatives

Earnings Update

Workforce Reduction

Management Change

Management Change

Earnings Update

Credit Agreement Update

Financial Update

Annual Meeting Voting Results

Appointment, Repayment of C...

Financial Update

Earnings Reports

Press Release and Corporate...

Earnings Reports

Earnings Reports

Completion of Acquisition

Annual Meeting Approval

Acquisition Agreement

Earnings Reports

Departure of Directors or C...

Financial Update

Earnings Reports

External Links:

Sravan K. Emany is resigning as COO and CFO of Ironwood Pharmaceuticals, effective December 18, 2024, with no disagreements reported; Thomas McCourt will serve as interim principal financial officer until a replacement is found.

AI Assistant

IRONWOOD PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.